Renal-specific oxido-reductase (RSOR), an enzyme relevant to diabetic nephropathy, is exclusively expressed in renal tubules. Studies were initiated to determine whether, like other tubular specific proteins, it selectively modulates tubulogenesis. Northern blot analyses revealed a ∼1.5 kb transcript, and RSOR expression was detectable in mice embryonic kidneys at day-13, gradually increased by day-17 and extended into neo-and post-natal periods. RSOR mRNA and protein expression was confined to proximal tubules, commencing at day-17 and increasing subsequently, but remained absent in glomeruli and medulla. Treatment with RSOR antisense oligodeoxynucleotide resulted in a dose-dependant dysmorphogenesis of metanephric explants harvested at day-13. The explants were smaller, had expanded mesenchyme, and the population of tubules was markedly decreased. The glomeruli were unaffected, as assessed by mRNA expression of glomerular epithelial protein1 and reactivity with wheat germ agglutinin. Antisense treatment led to a selective reduction of RSOR mRNA. Immunoprecipitation also indicated a selective translational blockade of RSOR. These findings suggest that RSOR is developmentally regulated, exhibits a distinct spatio-temporal distribution and probably plays a role in
INTRODUCTION 3
Formation of nephrons commences with the intercalation of ureteric epithelial bud into the mesenchyme, as a result there is a phenotypic induction in which mesenchymal cells acquire the properties of epithelial cells [22, 24, 26] . Subsequently, the nascent nephrons undergo a series of developmental stages, i.e., condensate, S-shaped body, precapillary and capillary. The S-shaped body stage has been regarded as the precursor of two distinct processes, i.e., glomerulogenesis and tubulogenesis, and they are related to the spatial segmentation of the S-shaped body.
Relative to the anatomical location of the ureteric bud branches, the S-shaped body has a distal and proximal convolution or pole. The cells in the distal pole, i.e., those near the tips of ureteric bud branches, are believed to be the precursors of epithelial-lined tubular structures, whereas those in the proximal convolution develop into a renal glomerulus. The glomerulus during the latter part of the gestation (day-13 onwards in mice) is capillarized by the process of vasculogenesis and angiogenesis [1] , while the tubular epithelial cells undergo multiplication as well as differentiation [13] . These developmental processes are regulated by a number of factors or macromolecules, i.e., extracellular matrix glycoproteins, their receptors, cell adhesions molecules (CAMs), proto-oncogenes, tyrosine kinase receptors, growth factors and transcription factors [15] .
During this time frame the tubular epithelia acquire polarity characteristics and reabsorptive transport properties [13, 26] . The latter are believed to influence the handling of water, ions, amino acids and sugars by the renal tubular epithelia [20] . In the kidney there are two types glucose transporters: 1) facilitative glucose transporters, i.e., GLUT-1, -2, -4 and -5, and 2) sodium glucose co-transporters, i.e., SGLT-1 and -2. The latter are exclusively expressed in the tubules, and has been shown to selectively modulate tubulogenesis [31] . Similarly, other molecules that are exclusively expressed in the tubules, e.g., tubulo-interstitial nephritis antigen, also selectively regulate tubulogenesis while glomerulogenesis is unaffected [16] . Using representational difference analysis of cDNA, an enzyme that is exclusively expressed in the kidney tubules has been identified recently in the newborn mice [32] . The enzyme has been termed renal specific oxido-reductase (RSOR) and is relevant to glucose metabolism, and it begins to express in the tubules during the time frame as the sodium glucose transporter-1, SGLT-1 [31] . In view of these properties of RSOR, studies were undertaken to assess its developmental regulation during metanephrogenesis in mice and to delineate its role in tubulogenesis vs glomerulogenesis.
MATERIALS AND METHODS
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Animals: ICR mice (Harlan Sprague Dawley, Inc., Indianapolis, IN) were used for paired male and female mating, and appearance of the vaginal plug was designated as day-0 of gestation.
The mouse embryos were harvested at day-13, -17 and -19 (newborn) of gestation, and metanephroi were isolated. In addition, kidneys from 1-, 2-and 3-weeks-old mice were procured.
Gene expression of RSOR in developing kidneys by Northern blot analyses and in situ hybridization tissue autoradiography: RNA from embryonic kidneys at various stages of gestation and from kidneys at 1-and 3-weeks-old mice was extracted by the guanidinium isothiocyanate-CsCl centrifugation method [8] . Equal amounts of RNA were glyoxalated and subjected to 1% agarose gel electrophoresis in 10 mM sodium phosphate buffer, pH 7.0. A Northern blot was prepared by transferring the RNA to a nylon filter membrane (Amersham Corp., Arlington Heights, IL). The membrane blot was hybridized with [α-
32 P]-dCTP-labeled mouse RSOR cDNA. The membrane filter was washed under high stringency conditions with 0.1X SSC and 0.1% SDS at 60 o C, and autoradiograms were prepared. Same blot was also hybridized with a β-actin probe.
For in situ hybridization studies, the RSOR cDNA was subcloned into pBluescript KS(+), and was used as a template for generating sense-and antisense-riboprobes by using Riboprobe In available in the GenBank database, and their specificity was determined by S 1 nuclease protection assay, as described in our previous publications [19, 30] .
A total of about 750 embryonic kidneys at day-13 of gestation were harvested and maintained in culture for 1 to 4 days. The details of the metanephric culture have been described previously [19, 30] . Briefly, the explants were placed on top of a 0.8 µm nucleopore filter (Millipore Corp., Bedford, MA) and transferred to a petri dish containing serum-free culture medium. The medium consisted of equal volumes of Dulbecco's modified Eagles' medium (DMEM) and Ham's nutrient mixture F12, supplemented with iron-poor transferrin (50 µg/ml) and streptomycin and penicillin (100 µg/ml). The ODNs were added to the culture media daily at concentrations ranging from 0.5 to 1.5 µM for 1-4 days. At these concentrations, the ODNs usually retain their translational blockade specificity with no discernible cytotoxic effects [7, 19, 30] . About 250 6 explants per variable, i.e., sense, antisense and nonsense, were processed for light microscopy, quantitative RT-PCR analyses, and immunofluorescence and immunoprecipitation studies as described in the following sections. Another ∼300 untreated explants, serving as control, were also processed for various studies. For light microscopy, the EPON embedded explants were sectioned at the midplane such that the section included a maximum number of ureteric bud iterations, both the poles and the hilum of the embryonic kidney.
Competitive RT-PCR analyses of antisense-ODN-treated embryonic kidneys: Competitive RT-PCR analyses were carried out as to assess the effect of antisense-ODNs on RSOR mRNA expression, the technical details of this method have been described previously [19, 30] . Briefly, total RNA was isolated from 50 explants per variable by acid guanidinium isothiocyanate-phenolchloroform extraction method [9] . Extracted RNAs were treated with RNase-free DNase and their nucleotide sequences were confirmed by the dideoxy chain termination method [23] . To generate competitive DNA template for RSOR, the primers were added into the minigene construct prepared in our laboratory previously [17] . With the use of this modified competitive DNA template, the expected size of the PCR product is 211 bp. This minigene construct contains the primer sequences for β-actin with an expected size of the PCR product of 224 bp. Another control used in the antisense experiment included the determination of mRNA expression of glomerular epithelial protein 1 (GLEPP1). The latter is expressed exclusively in the renal glomerular podocytes and is absent in the tubules [27] . For GLEPP1, the respective sense and antisense primers were: 5'-GGGCTGGTGTCGGAA ATGAGGT-3' and 5'-CAACTAGCAAAGGGCCTGAAAG-3'. Using these primers, the expected size of the PCR product from embryonic renal cDNA is 467 bp. These primers were also added into the minigene 7 construct to generate the competitive DNA template. The expected size of the PCR product using the competitive DNA template and GLEPP1 primers is 271 bp.
For quantitative RT-PCR analyses, fixed amount of cDNAs (1 µg in 1 µl) from antisense-and nonsense-ODN-treated explants and serial logarithmic dilutions of the competitive template DNA (500 ng/µl) of RSOR were co-amplified [12] . PCR products were analyzed. The ratios between the densitometric readings of wild type and mutant PCR-DNA products were plotted using a logarithmic scale on the ordinate (y-axis) against the logarithmic dilutions of the competitive template DNA on the abscissa (x-axis).
Expression of de novo synthesized RSOR in antisense-ODN-treated renal explants:
Immunoprecipitation studies were performed on renal explants treated with various ODNs, i.e.,
antisense, sense and nonsense, to assess the translational blockade of RSOR. Treated explants were maintained in the organ culture system and labelled with [ 35 S]-methionine (0.25 mCi/ml) for 12 hours prior to the termination of culture. They were rinsed with the culture medium. They were then extracted with 2 ml of immunoprecipitation (IP) buffer (50 mM Tris HCl pH 7.5, 50 mM NaCl, 0.02% NaN 3 , 0.25 mM dithiothreitol, 1% Triton-X100, 10 mM ε-amino-η-caproic acid, 10 mM benzamidine HCl, 5 mM N-ethylmaleimide and 1 mM PMSF) by vigorous shaking for 4 hours at 4 o C. The extract was microfuged and supernatant was saved. Total incorporated radioactivity was determined in the supernatant after trichloroacetic acid precipitation. Samples with equal amounts of radioactivity (∼5 X 10 6 dpm) in a volume of 500 µl were used for immuno-precipitation as previously described [19, 30] . 10 µl of polyclonal rabbit anti-RSOR antibody was added and gently swirled at 4 o C in an orbital shaker for 12 hrs at 4 o C. The antigen:antibody complexes were briefly microfuged, and transferred to a fresh Eppendorf tube. After addition of 10 mg of protein-A Sepharose 4B (Pharmacia LKB Biotechnology, Piscataway, NJ), in a volume of 100 µl of the IP 8 buffer, the complexes were further incubated for 1 hour at 4 o C. They were then centrifuged for 1 min at 10,000 X g, and the pellets were then washed extensively with the IP buffer. Pellets containing the complexes were suspended in 20 µl of sample buffer (4% SDS, 150 mM Tris-HCl, pH 6.8, 20% glycerol, 0.125% bromophenol blue, 1 µl β-mercaptoethanol and 1 mM PMSF).
Aliquots of the samples were boiled and subjected to 10% SDS-PAGE. The gels were fixed in 10% acetic acid and 10% methanol, treated with 1M salicylic acid, vacuum dried, and autoradiograms were prepared.
Tissue expression of RSOR, wheat germ agglutinin (WGA) and glomerular epithelial protein 1 (GLEPP1) in antisense-treated metanephric explants: Tissue expression of RSOR in tubules of antisense-and sense-or nonsense-ODN renal embryonic explants was assessed by immunofluorescence microscopy as described above. To evaluate the concentration of nascent glomeruli in the antisense-ODN treated explants, expression of WGA and GLEPP1 was assessed, since both of them are regarded as markers for the podocyte, the latter is a highly differentiated cell of the renal glomerulus. The adjacent serial sections were stained with anti-RSOR and WGA conjugated with rhodamine (Sigma Chemical Co., St. Louis, MO) at a dilution of 1:100 and photographed as described above. The cryostat sections that were from the midplane of explant and included a maximum number of ureteric bud iterations, and tubules and glomeruli were examined. Finally, the mRNA expression of GLEPP1 was determined in the RSOR antisense-treated explant by in situ tissue autoradiography. The 467-bp product generated above by PCR was used to prepare the GLEPP1 riboprobe. The conditions for hybridization of GLEPP1 riboprobe and preparation of the autoradiograms were essentially the same as described for the RSOR.
RESULTS
RSOR mRNA expression by Northern blot analyses:
A single mRNA transcript of ∼1.5 kb size in kidneys harvested from day-13 and day-17 embryos and newborn, and 1-and 3 weeks-old mice was observed (Figure1A). The mRNA expression of RSOR was detectable at day-13 of gestation when ∼25 µg of total RNA, isolated from ∼100 explants, was used. The RSOR mRNA expression steadily increased during the various stages of gestation, and it notably accentuated during neo-and post-natal stages, suggesting thereby that it is developmentally regulated. No other transcript was seen throughout the development, indicating that no other its related isoform, e.g., like for aldose reductase or aldehyde reductase, is expressed during the embryonic 
Expression of RSOR by tissue in situ autoradiography and immunofluorescence microscopy:
Since RSOR is developmentally regulated, in situ hybridization and immunofluorescence studies were performed to examine its spatio-temporal distribution in embryonic and neonatal kidneys (Figure 2) . At day-13, the expression was not distinct, and a very mild reactivity was observed in the ureteric bud branches in some of the metanephric explants (Figures 2A and 2G) . At day-17, the RSOR expression was seen in the cortical tubules in the form of clusters, and the message was absent in the medulla (Figures 2B and 2H) . In the newborn, the pattern of mRNA expression was similar to that seen at day-17, although it was accentuated (Figures 2C and 2I) . The mRNA expression was further accentuated and became diffuse amongst the cortical tubules in the kidneys of 1-week-old mice (Figures 2D and 2J) . However, it remained absent in the medulla.
Also no message was detected in the renal glomeruli (arrowheads in figure 2J ). In the kidneys of There was an overall dose-dependent reduction in the size of the explants. At a concentration of 0.5 µM of ODN in the medium (Figures 4C and 4G) , the nephron population was reduced and mesenchyme was expanded. The reduction of nephrons was mainly confined to the tubules, although a very mild decrease in the glomeruli was observed as well. The mesenchyme in deeper portion of the explant was loose. At 1.0 µM concentration of the antisense-ODN, the size of explants was further reduced (figures not included). At 1.5 µM of antisense-ODN the number of the tubules was remarkably reduced, and very few tubules were seen (Figures 4D and 4H) . The glomerular population seemed to be unaffected, and a number of them were readily discernible (arrowheads in figure 4H ). They seemed to be aggregated perhaps because of the loss of tubules. The ureteric bud branches were rudimentary, and their normal dichotomous iterations were not seen. The mesenchyme seemed to be enormously expanded.
Immunofluorescence studies were performed on the metanephric explants treated with C, lanes 1-8) , enabling densitometric analyses to obtain a ratio of the intensities of the bands.
The graphic plots are not included since they have been shown in several of our previous publications [19, 30] and only the original data, i.e., electrophoretograms, are included to indicate and aldose reductase (AKR1B) have been isolated and characterized from the placenta [10, 29] .
Since placenta has a dual origin, i.e., chorion frondosum from the fetus and decidua basalis from the mother, it is likely that these enzymes may be expressed in fetal tissues as well. In this regard, the mRNA expression of AKR1B has been studied in human fetal tissues, although no information is available in the literature as to the spatio-temporal expression of AKR1A during embryonic development. The AKR1B is mildly expressed in certain fetal tissues, including fetal brain, lung, liver, eye and kidney [6] . Beyond AKR1B expression in fetal tissues, no further functional studies have been performed. However, further detailed studies describing spatiotemporal expression of AKR1B has been described in the rat eye [3] , and interest in this area may be due to its relevance in one of the common complication of diabetes, i.e., cataractogenesis. At day-13 of murine gestation there is a relatively high degree of mRNA expression in the optic cup compared to other organs. The level of expression continues to be high in subsequent stages, but is confined to the germinative zone, the latter being the source of cells that become lens fibers. Because of such a spatio-temporal expression the AKR1B has been implicated in lens fiber morphogenesis [3] . In the rat kidney, AKR1B mRNA expression is mostly detectable at very late stage of the gestation and is mainly seen in medullary tips of the newborn kidney. Its expression rises rapidly and by post-natal day-12 reaches to levels comparable to the adult kidney [4, 25] . Since AKR1B expression in the kidney is a late occurrence it probably has a lessor role in the renal morphogenesis.
In regard to the RSOR, it is exclusively expressed in the fetal kidney and exhibits strict spatiotemporal distribution. The mRNA expression is detectable at day-13 of mouse gestation.
Thereafter, it steadily increases during the later stages of gestation, and reaches levels comparable with the adult kidney by 3-weeks of postnatal life (figure 1). Since RSOR expression is detectable just after the commencement of nephrogenesis, it is conceivable that it may have a role in metanephrogenesis like other macromolecules that are expressed at that stage of embryonic development [15, 26] . Some of the molecules that are known to regulate nephrogenesis are exclusively expressed in the tubules and they selectively modulate tubulogenesis [16, 31] . Since RSOR is exclusively expressed in the tubules right at the onset of nephrogenesis and is confined to the proximal tubules (figures 2 and 3), it would be of interest to investigate whether it affects tubulogenesis vs glomerulogenesis or both. So far the molecules that have been described to exclusively modulate tubulogenesis include extracellular matrix proteins, i.e., tubulo-interstitial nephritis antigen and an integral membrane proteins, SGLT-1 [16,
Here, a relevant issue therefore would be as to whether or not a cytosolic protein like RSOR can modulate tubular development. Also, since it is difficult to assume that a given molecule is relevant to nephrogenesis or tubulogenesis simply because it is developmentally regulated, one has to prove this by performing in vitro or in vivo gene disruption experiments.
To address the above issues, in vitro antisense-ODN experiments were performed. This technology has yielded critical information in various developmental processes in the past, provided appropriate controls are included in a given experiment [5] . In cell culture systems, a high dose of various antisense-oligodeoxnucleotides (ODNs) (>10 µM) can be used, whereas, in organ culture system like that of the kidney, this dose is quite toxic, i.e., one may observe foci of necrosis or apoptosis in antisense-treated explants. In view of this fact, the experiments were performed at concentrations ranging from 0.5 to 1.5 µM, which yielded dose-dependent alterations in the metanephric explants and no discernible toxicity was observed ( Interestingly, the effects described above are reminiscent of the previously reported results for sodium glucose-transporter-1 (SGLT-1) that exhibits similar spatio-temporal expression in the kidney during embryonic life [31, 33] . Having these two macromolecules with similar spatiotemporal expression and both involved in glucose energy metabolism, it is conceivable that the glycolytic pathway plays a critical role in tubular maturation as compared to its relevance in glomerular development. This is more of a speculation at present and further studies on the expression of these molecules during development in kidneys exposed to high glucose concentrations are required. In this regard, it is known that high glucose ambience can induce dysmorphogenesis of the embryonic kidney in in vitro culture systems [17] . Also, it is worth mentioning here that hyperglycemia, besides causing diabetic nephropathy [18, 21] , is also known to cause renal developmental abnormalities in 2-3% offsprings of poorly controlled juvenile diabetics, which may be part of the "caudal regression syndrome" or may solely involve the urogenital system [11] .
In summary, the results of this investigation suggest that RSOR, an enzyme involved in the glucose metabolism, is developmentally regulated and it modulates renal tubulogenesis in an in vitro organ culture system. Finally, it is anticipated that the results of this investigation would provide an impetus for future in vivo genetic manipulation studies, i.e., transgenic and knock-out mice experiments, to elucidate the role of RSOR in renal development both under normoglycemic and hyperglycemic states. 
